Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Wulf

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Annals of Hematology|March 2, 2011
Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescueKarin Hohloch, Carsten Oliver Sahlmann, Vijai J Lakhani, et al.
Hematological Oncology|April 3, 2022
Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysisEvgenii Shumilov, Justin Hasenkamp, Markus Maulhardt, et al.
Bone Marrow Transplantation|November 11, 2018
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced diseaseGerald Wulf, Justin Hasenkamp, Wolfram Jung, et al.
Frontiers in Molecular Biosciences|June 6, 2020
Digital-Droplet PCR for Quantification of CD19-Directed CAR T-CellsThomas Mika, Abdelouahid Maghnouj, Susanne Klein-Scory, et al.
Annals of Hematology|May 12, 2016
Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphomaKarin Hohloch, Samira Zeynalova, Björn Chapuy, et al.
Plos One|January 21, 2017
Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective StudyChristine Neuchel, Daniel Fürst, Dietger Niederwieser, et al.
Cancer Medicine|May 21, 2024
Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in EuropeEnver Aydilek, Gerald Wulf, Friedrich Schwarz, et al.
Haematologica|January 7, 2017
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantationDaniel Fürst, Dietger Niederwieser, Donald Bunjes, et al.
Blood Advances|July 14, 2023
Real-world results of CAR T-cell therapy for large B-cell lymphoma with CNS involvement: a GLA/DRST studyFrancis Ayuk, Nico Gagelmann, Bastian von Tresckow, et al.
International Journal of Laboratory Hematology|June 22, 2019
Digital droplet PCR-based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantationThomas Mika, Alexander Baraniskin, Swedlana Ladigan, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Annals of Hematology|March 2, 2011
Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescueKarin Hohloch, Carsten Oliver Sahlmann, Vijai J Lakhani, et al.
Hematological Oncology|April 3, 2022
Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysisEvgenii Shumilov, Justin Hasenkamp, Markus Maulhardt, et al.
Bone Marrow Transplantation|November 11, 2018
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced diseaseGerald Wulf, Justin Hasenkamp, Wolfram Jung, et al.
Frontiers in Molecular Biosciences|June 6, 2020
Digital-Droplet PCR for Quantification of CD19-Directed CAR T-CellsThomas Mika, Abdelouahid Maghnouj, Susanne Klein-Scory, et al.
Annals of Hematology|May 12, 2016
Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphomaKarin Hohloch, Samira Zeynalova, Björn Chapuy, et al.
Plos One|January 21, 2017
Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective StudyChristine Neuchel, Daniel Fürst, Dietger Niederwieser, et al.
Cancer Medicine|May 21, 2024
Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in EuropeEnver Aydilek, Gerald Wulf, Friedrich Schwarz, et al.
Haematologica|January 7, 2017
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantationDaniel Fürst, Dietger Niederwieser, Donald Bunjes, et al.
Blood Advances|July 14, 2023
Real-world results of CAR T-cell therapy for large B-cell lymphoma with CNS involvement: a GLA/DRST studyFrancis Ayuk, Nico Gagelmann, Bastian von Tresckow, et al.
International Journal of Laboratory Hematology|June 22, 2019
Digital droplet PCR-based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantationThomas Mika, Alexander Baraniskin, Swedlana Ladigan, et al.
Pageof 14